Conversely in CD56- AML, CD200 expression was associated with a lower survival probability: 3-year OS was 57% in CD200-, 35% in CD200-low and 0% in CD200-high patients (p = 0.03; Figure 4a). The gene discussed is CD200; the disease is acute myeloid leukemia.